The allele 4 of neck region liver-lymph node-specific ICAM-3-grabbing integrin variant is associated with spontaneous clearance of hepatitis C virus and decrease of viral loads

Clinical Microbiology and Infection

Volumn 20, Issue 5, 2014, Pages

  Ezzikouri, S ^a   Rebbani, K ^a   Fakhir, F Z ^a   Alaoui, R ^b   Nadir, S ^b   Diepolder, H ^c   Thursz, M ^d   Khakoo, S I ^e   Benjelloun, S ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^c UNIVERSITY OF MUNICH   (Germany)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chronic hepatitis C; DC SIGNR; Gene polymorphism; Outcome; Viral loads

Indexed keywords

INTERLEUKIN 28B; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CLEC4M PROTEIN, HUMAN; LECTIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HOMOZYGOTE; HUMAN; INTERLEUKIN 28B GENE; LIVER LYMPH NODE SPECIFIC ICAM 3 GRABBING INTEGRIN GENE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOROCCO; NECK; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TANDEM REPEAT; VIRAL CLEARANCE; VIRUS LOAD; GENETICS; HEPACIVIRUS; LIVER; LYMPH NODE; REMISSION; VARIABLE NUMBER OF TANDEM REPEAT;

HEPATITIS C VIRUS;

AGED; CELL ADHESION MOLECULES; FEMALE; GENE FREQUENCY; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LECTINS, C-TYPE; LIVER; LYMPH NODES; MALE; MIDDLE AGED; MINISATELLITE REPEATS; MOROCCO; POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; REMISSION, SPONTANEOUS; VIRAL LOAD;

EID: 84901621770     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12403     Document Type: Article

References (35)

1. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 23-61.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558-567.
3. Schmidt J, Thimme R, Neumann-Haefelin C. Host genetics in immune-mediated hepatitis C virus clearance. Biomark Med 2011; 5: 155-169.
4. Taylor DR, Silberstein E. Innate immunity and hepatitis C virus: eluding the host cell defense. Front Biosci 2009; 14: 4950-4961.
5. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001; 193: 671-678.
6. Pohlmann S, Soilleux EJ, Baribaud F et al. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 2001; 98: 2670-2675.
7. Soilleux EJ, Morris LS, Leslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71: 445-457.
8. Cormier EG, Durso RJ, Tsamis F et al. L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proc Natl Acad Sci U S A 2004; 101: 14067-14072.
9. Gardner JP, Durso RJ, Arrigale RR et al. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc Natl Acad Sci U S A 2003; 100: 4498-4503.
10. Lozach PY, Amara A, Bartosch B et al. C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 2004; 279: 32035-32045.
11. Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A et al. DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2. J Biol Chem 2003; 278: 20358-20366.
12. Pohlmann S, Zhang J, Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003; 77: 4070-4080.
13. Ludwig IS, Lekkerkerker AN, Depla E et al. Hepatitis C virus targets DC-SIGN and L-SIGN to escape lysosomal degradation. J Virol 2004; 78: 8322-8332.
14. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001; 276: 28939-28945.
15. Feinberg H, Guo Y, Mitchell DA, Drickamer K, Weis WI. Extended neck regions stabilize tetramers of the receptors DC-SIGN and DC-SIGNR. J Biol Chem 2005; 280: 1327-1335.
16. Liu H, Zhu T. Determination of DC-SIGN and DC-SIGNR repeat region variations. Methods Mol Biol 2005; 304: 471-481.
17. Chan VS, Chan KY, Chen Y et al. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet 2006; 38: 38-46.
18. Liu H, Carrington M, Wang C et al. Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J Infect Dis 2006; 193: 698-702.
19. Wichukchinda N, Kitamura Y, Rojanawiwat A et al. The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses 2007; 23: 686-692.
20. Falkowska E, Durso RJ, Gardner JP et al. L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles. J Gen Virol 2006; 87: 2571-2576.
21. Brahim I, Akil A, el Mtairag M et al. Morocco underwent a drift of circulating hepatitis C virus subtypes in recent decades. Arch Virol 2012; 157: 515-520.
22. Ezzikouri S, Alaoui R, Rebbani K et al. Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in moroccan patients. PLoS ONE 2013; 8: e54793.
23. Leckband DE, Menon S, Rosenberg K, Graham SA, Taylor ME, Drickamer K. Geometry and adhesion of extracellular domains of DC-SIGNR neck length variants analyzed by force-distance measurements. Biochemistry 2011; 50: 6125-6132.
24. Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 2000; 165: 2937-2942.
25. Barreiro LB, Patin E, Neyrolles O, Cann HM, Gicquel B, Quintana-Murci L. The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region. Am J Hum Genet 2005; 77: 869-886.
26. Kobayashi N, Nakamura HT, Goto M et al. Polymorphisms and haplotypes of the CD209L gene and their association with the clinical courses of HIV-positive Japanese patients. Jpn J Infect Dis 2002; 55: 131-133.
27. Boily-Larouche G, Zijenah LS, Mbizvo M, Ward BJ, Roger M. DC-SIGN and DC-SIGNR genetic diversity among different ethnic populations: potential implications for pathogen recognition and disease susceptibility. Hum Immunol 2007; 68: 523-530.
28. Li H, Wang JX, Wu DD, Wang HW, Tang NL, Zhang YP. The origin and evolution of variable number tandem repeat of CLEC4M gene in the global human population. PLoS ONE 2012; 7: e30268.
29. Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Dhole TN. Role of homozygous DC-SIGNR 5/5 tandem repeat polymorphism in HIV-1 exposed seronegative North Indian individuals. J Clin Immunol 2008; 28: 50-57.
30. Li-Jun X, Brockmeyer NH, Bader A, Hang-Ping Y, Zhi-Gang W, Nanping W. HIV-1 infected Germans have more variations on neck region of DC-specific intercellular adhesion molecule-3-grabbing nonintegrin than HIV-1 infected Chinese. Eur J Med Res 2008; 13: 59-62.
31. Lichterfeld M, Nischalke HD, van Lunzen J et al. The tandem-repeat polymorphism of the DC-SIGNR gene does not affect the susceptibility to HIV infection and the progression to AIDS. Clin Immunol 2003; 107: 55-59.
32. Xu L, Li Q, Ye H et al. The nine-repeat DC-SIGNR isoform is associated with increased HIV-RNA loads and HIV sexual transmission. J Clin Immunol 2010; 30: 402-407.
33. Barreiro LB, Neyrolles O, Babb CL et al. Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility. Hum Immunol 2007; 68: 106-112.
34. Nattermann J, Ahlenstiel G, Berg T et al. The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. J Viral Hepat 2006; 13: 42-46.
35. Snyder GA, Ford J, Torabi-Parizi P et al. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor. J Virol 2005; 79: 4589-4598.